Late-onset <i>NPM1</i> mutation in a MYC-amplified relapsed/refractory acute myeloid leukemia patient treated with gemtuzumab ozogamicin and glasdegib

Affiliations

Sonia Jaramillo: Department of Internal Medicine V, Heidelberg University Hospital
Michael Scherer: Centre for Genomic Regulation (CRG), The Barcelona Institute of Science and Technology, Barcelona
Chelsea Szu-Tu: Centre for Genomic Regulation (CRG), The Barcelona Institute of Science and Technology, Barcelona
Sergi Beneyto-Calabuig: Centre for Genomic Regulation (CRG), The Barcelona Institute of Science and Technology, Barcelona
Carsten Müller-Tidow: Department of Internal Medicine V, Heidelberg University Hospital, Germany; Molecular Medicine Partnership Unit (MMPU), University of Heidelberg and European Molecular Biology Laboratory, Heidelberg
Richard F. Schlenk: Department of Internal Medicine V, Heidelberg University Hospital, Germany; NCT-Trial Center, National Center of Tumor Diseases, Heidelberg University Hospital and German Cancer Research Center
Michael Hundemer: Department of Internal Medicine V, Heidelberg University Hospital
Lars Velten: Centre for Genomic Regulation (CRG), The Barcelona Institute of Science and Technology, Barcelona, Spain; Universitat Pompeu Fabra (UPF), Barcelona
Caroline Pabst: Department of Internal Medicine V, Heidelberg University Hospital, Germany; Molecular Medicine Partnership Unit (MMPU), University of Heidelberg and European Molecular Biology Laboratory, Heidelberg

Abstract

Not available.

ISSN: 0390-6078 (Print); 1592-8721 (Online)
Publisher: Ferrata Storti Foundation
Country of publisher: Italy
LCC subjects: Medicine: Internal medicine: Specialties of internal medicine: Diseases of the blood and blood-forming organs
Website: http://www.haematologica.org